404 related articles for article (PubMed ID: 37400628)
1. Regulatory T cells in autoimmune kidney diseases and transplantation.
Mikami N; Sakaguchi S
Nat Rev Nephrol; 2023 Sep; 19(9):544-557. PubMed ID: 37400628
[TBL] [Abstract][Full Text] [Related]
2. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
3. Treg Enhancing Therapies to Treat Autoimmune Diseases.
Eggenhuizen PJ; Ng BH; Ooi JD
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases.
Ohkura N; Sakaguchi S
Cell Res; 2020 Jun; 30(6):465-474. PubMed ID: 32367041
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the MT-2 Treg-like cell line in the presence and absence of forkhead box P3 (FOXP3).
McCullough MJ; Tune MK; Cabrera JC; Torres-Castillo J; He M; Feng Y; Doerschuk CM; Dang H; Beltran AS; Hagan RS; Mock JR
Immunol Cell Biol; 2024 Mar; 102(3):211-224. PubMed ID: 38288547
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T Cells for Control of Autoimmunity.
Kawakami R; Sakaguchi S
Adv Exp Med Biol; 2024; 1444():67-82. PubMed ID: 38467973
[TBL] [Abstract][Full Text] [Related]
7. Opportunities for Treg cell therapy for the treatment of human disease.
Bluestone JA; McKenzie BS; Beilke J; Ramsdell F
Front Immunol; 2023; 14():1166135. PubMed ID: 37153574
[TBL] [Abstract][Full Text] [Related]
8. New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression.
Mikami N; Kawakami R; Sakaguchi S
Curr Opin Immunol; 2020 Dec; 67():36-41. PubMed ID: 32827951
[TBL] [Abstract][Full Text] [Related]
9. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
Front Immunol; 2018; 9():2359. PubMed ID: 30369931
[TBL] [Abstract][Full Text] [Related]
10. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
[TBL] [Abstract][Full Text] [Related]
11. The role of FOXP3
Mohr A; Atif M; Balderas R; Gorochov G; Miyara M
Clin Exp Immunol; 2019 Jul; 197(1):24-35. PubMed ID: 30830965
[TBL] [Abstract][Full Text] [Related]
12. The Family of IL-10-secreting CD4+ T cells.
Fujio K; Okamura T; Yamamoto K
Adv Immunol; 2010; 105():99-130. PubMed ID: 20510731
[TBL] [Abstract][Full Text] [Related]
13. Bet v 1-specific T-cell receptor/forkhead box protein 3 transgenic T cells suppress Bet v 1-specific T-cell effector function in an activation-dependent manner.
Schmetterer KG; Haiderer D; Leb-Reichl VM; Neunkirchner A; Jahn-Schmid B; Küng HJ; Schuch K; Steinberger P; Bohle B; Pickl WF
J Allergy Clin Immunol; 2011 Jan; 127(1):238-45, 245.e1-3. PubMed ID: 21211658
[TBL] [Abstract][Full Text] [Related]
14. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
15. A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives.
Han Z; Ma K; Tao H; Liu H; Zhang J; Sai X; Li Y; Chi M; Nian Q; Song L; Liu C
Front Immunol; 2022; 13():826732. PubMed ID: 35251009
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges.
Goswami TK; Singh M; Dhawan M; Mitra S; Emran TB; Rabaan AA; Mutair AA; Alawi ZA; Alhumaid S; Dhama K
Hum Vaccin Immunother; 2022 Dec; 18(1):2035117. PubMed ID: 35240914
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
Singh AK; Horvath KA; Mohiuddin MM
Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
[TBL] [Abstract][Full Text] [Related]
18. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
[TBL] [Abstract][Full Text] [Related]
19. TREG-cell therapies for autoimmune rheumatic diseases.
Miyara M; Ito Y; Sakaguchi S
Nat Rev Rheumatol; 2014 Sep; 10(9):543-51. PubMed ID: 24980140
[TBL] [Abstract][Full Text] [Related]
20. Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.
Liu YH; Mölzer C; Makinen K; Kamoi K; Corbett CLC; Klaska IP; Reid DM; Wilson HM; Kuffová L; Cornall RJ; Forrester JV
Front Immunol; 2020; 11():2071. PubMed ID: 33013877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
